Premenstrual syndrome and migraine

Neurological Sciences

Volumn 33, Issue SUPPL. 1, 2012, Pages

  Allais, Gianni ^a   Castagnoli Gabellari, Ilaria ^a   Burzio, Chiara ^a   Rolando, Sara ^a   De Lorenzo, Cristina ^a   Mana, Ornella ^a   Benedetto, Chiara ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Menstrual migraine; Premenstrual disphoric disorder; Premenstrual syndrome

Indexed keywords

ANGELICA SINENSIS EXTRACT; CIMICIFUGA RACEMOSA EXTRACT; DAIDZEIN; DEXAMETHASONE; DROSPIRENONE; EQUOL; GENISTEIN; GINKGO BILOBA EXTRACT; GINKGOLIDE B; MAGNESIUM; MAGNESIUM DERIVATIVE; MAGNESIUM OXIDE; MAGNESIUM PYRROLIDONE CARBOXYLIC ACID; MEFENAMIC ACID; NAPROXEN; NAPROXEN PLUS SUMATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PHYTOESTROGEN; PLACEBO; PYRIDOXINE; RIBOFLAVIN; RIZATRIPTAN; TRIPTAN DERIVATIVE; UBIDECARENONE; UNCLASSIFIED DRUG;

COMORBIDITY; CONFERENCE PAPER; DISEASE ASSOCIATION; EMOTIONAL DISORDER; HEADACHE; HUMAN; MENSTRUAL MIGRAINE; MIGRAINE WITH AURA; PHYSICAL DISEASE; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOYBEAN; SYMPTOMATOLOGY;

CONTRACEPTIVES, ORAL, COMBINED; FEMALE; GINKGO BILOBA; GINKGOLIDES; HUMANS; LACTONES; MAGNESIUM; MIGRAINE DISORDERS; PREMENSTRUAL SYNDROME;

EID: 84864200479     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-012-1054-5     Document Type: Conference Paper

References (27)

1. Martin VT, Wernke S, Mandell K et al (2006) Symptoms of premenstrual syndrome and their association with migraine headache. Headache 46(1):125-137
2. Johnson SR (2004) Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitioners. Obstet Gynecol 104(4):845-859 (Pubitemid 40458816)
3. Halbreich U, Backstrom T, Eriksson E et al (2007) Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecol Endocrinol 23(3):123-130 (Pubitemid 46570210)
4. World Health Organization (WHO) (1996) International classification of diseases, 10th revision. WHO, Geneva
5. American College of Obstetricians and Gynecologists (2000) Premenstrual syndrome. National Guideline Clearinghouse, Washington, DC
6. American Psychiatric association (APA) (1994) Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC, pp 714-718
7. Royal College of Obstetricians and Gynaecologists (2007) Management of premenstrual syndrome. Green-top Guideline No. 48
8. Fragoso YD, Guidoni AC, de Castro LB (2009) Characterization of headaches in the premenstrual tension syndrome. Arq Neuropsiquiatr 67(1):40-42
9. Beckham JC, Krug LM, Penzien DB et al (1992) The relationship of ovarian steroids, headache activity and menstrual distress: a pilot study with female migraineurs. Headache 32(6):292-297
10. Facchinetti F, Neri I, Martignoni E et al (1993) The association of menstrual migraine with the premenstrual syndrome. Cephalalgia 13(6):422-425 (Pubitemid 24017460)
11. Sances G, Martignoni E, Fioroni L et al (1990) Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache 30(11):705-709
12. Al-Waili NS (2000) Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefenamic acid: double-blind study with placebo. Eur J Med Res 5(4):176-182
13. Facchinetti F, Fioroni L, Sances G et al (1989) Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study. Gynecol Obstet Invest 28(4):205-208 (Pubitemid 20009993)
14. Wood C, Jakubowicz D (1980) The treatment of premenstrual symptoms with mefenamic acid. Br J Obstet Gynaecol 87(7):627-630 (Pubitemid 10035683)
15. Mira M, McNeil D, Fraser IS et al (1986) Mefenamic acid in the treatment of premenstrual syndrome. Obstet Gynecol 68(3):395-398 (Pubitemid 16046506)
16. Facchinetti F, Sances G, Borella P et al (1991) Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 31(5):298-301
17. Facchinetti F, Borella P, Sances G et al (1991) Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol 78(2):177-181
18. Fathizadeh N, Ebrahimi E, Valiani M et al (2010) Evaluating the effect of magnesium and magnesium plus vitamin B6 supplement on the severity of premenstrual syndrome. Iran J Nurs Midwifery Res 15(Suppl 1):401-405
19. De Souza MC, Walker AF, Robinson PA et al (2000) A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health Gend Based Med 9(2):131-139 (Pubitemid 30168628)
20. Burke BE, Olson RD, Cusack BJ (2002) Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine. Biomed Pharmacother 56(6):283-288 (Pubitemid 35245311)
21. Ferrante F, Fusco E, Calabresi P et al (2004) Phyto-oestrogens in the prophylaxis of menstrual migraine. Clin Neuropharmacol 27(3):137-140 (Pubitemid 38746015)
22. Bryant M, Cassidy A, Hill C et al (2005) Effect of consumption of soy isoflavones on behavioural, somatic and affective symptoms in women with premenstrual syndrome. Br J Nutr 93(5):731-739 (Pubitemid 43906359)
23. Ozgoli G, Selselei EA, Mojab F et al (2009) A randomized, placebo-controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome. J Altern Complem Med 15(8):845-851
24. D'Andrea G, Bussone G, Allais G et al (2009) Efficacy of Ginkgolide B in the prophylaxis of migraine with aura. Neurol Sci 30(Suppl 1):S121-S124
25. Esposito M, Carotenuto M (2011) Ginkgolide B complex efficacy for brief prophylaxis of migraine in school-aged children: an open-label study. Neurol Sci 32(1):79-81
26. Lopez LM, Kaptein AA, Helmerhorst FM (2012) Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane database of systematic reviews 2. Art. No.:CD006586. doi:10.1002/14651858.CD006586.pub4
27. Sulak PJ, Kuehl TJ, Ortiz M et al (2002) Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol 186(6):1142-1149 (Pubitemid 34665050)